Literature DB >> 16301180

Endocannabinoids control the induction of cerebellar LTD.

Patrick K Safo1, Wade G Regehr.   

Abstract

The long-term depression (LTD) of parallel fiber (PF) synapses onto Purkinje cells plays a central role in motor learning. Endocannabinoid release and LTD induction both depend upon activation of the metabotropic glutamate receptor mGluR1, require postsynaptic calcium increases, are synapse specific, and have a similar dependence on the associative activation of PF and climbing fiber synapses. These similarities suggest that endocannabinoid release could account for many features of cerebellar LTD. Here we show that LTD induction is blocked by a cannabinoid receptor (CB1R) antagonist, by inhibiting the synthesis of the endocannabinoid 2-arachidonyl glycerol (2-AG), and is absent in mice lacking the CB1R. Although CB1Rs are prominently expressed presynaptically at PF synapses, LTD is expressed postsynaptically. In contrast, a previously described transient form of inhibition mediated by endocannabinoids is expressed presynaptically. This indicates that Purkinje cells release 2-AG that activates CB1Rs to both transiently inhibit release and induce a postsynaptic form of LTD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301180     DOI: 10.1016/j.neuron.2005.09.020

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  107 in total

Review 1.  On the induction of postsynaptic granule cell-Purkinje neuron LTP and LTD.

Authors:  Kaspar E Vogt; Marco Canepari
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

2.  Presynaptic CB1 receptors regulate synaptic plasticity at cerebellar parallel fiber synapses.

Authors:  Megan R Carey; Michael H Myoga; Kimberly R McDaniels; Giovanni Marsicano; Beat Lutz; Ken Mackie; Wade G Regehr
Journal:  J Neurophysiol       Date:  2010-11-17       Impact factor: 2.714

3.  Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.

Authors:  Vincenzo Di Marzo
Journal:  Nat Neurosci       Date:  2011-01       Impact factor: 24.884

4.  Numb deficiency in cerebellar Purkinje cells impairs synaptic expression of metabotropic glutamate receptor and motor coordination.

Authors:  Liang Zhou; Dong Yang; De-Juan Wang; Ya-Jun Xie; Jia-Huan Zhou; Lin Zhou; Hao Huang; Shuo Han; Chong-Yu Shao; Hua-Shun Li; J Julius Zhu; Meng-Sheng Qiu; Chris I De Zeeuw; Ying Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

5.  Short- and long-term depression of rat cerebellar parallel fibre synaptic transmission mediated by synaptic crosstalk.

Authors:  Païkan Marcaggi; David Attwell
Journal:  J Physiol       Date:  2006-11-16       Impact factor: 5.182

6.  Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol.

Authors:  Bela Szabo; Michal J Urbanski; Tiziana Bisogno; Vincenzo Di Marzo; Aitziber Mendiguren; Wolfram U Baer; Ilka Freiman
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

7.  The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons.

Authors:  Silvia Marinelli; Simone Pacioni; Tiziana Bisogno; Vincenzo Di Marzo; David A Prince; John R Huguenard; Alberto Bacci
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

8.  BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons.

Authors:  Peng Zhong; Yong Liu; Ying Hu; Tong Wang; Yong-ping Zhao; Qing-song Liu
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

9.  Neuromodulation at single presynaptic boutons of cerebellar parallel fibers is determined by bouton size and basal action potential-evoked Ca transient amplitude.

Authors:  Wei Zhang; David J Linden
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

Review 10.  Strength through diversity.

Authors:  Sacha B Nelson; Gina G Turrigiano
Journal:  Neuron       Date:  2008-11-06       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.